Details of the Drug

General Information of Drug (ID: DMIUKVW)

Drug Name

LTI-291

Synonyms

HZILSILAELSWKN-UHFFFAOYSA-N; 1919820-28-2; SCHEMBL17739965; SCHEMBL19024862; EX-A2518; BCP25413; HY-104038; CS-0026754; 5,7-dimethyl-N-((1r,4r)-4-(pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C20H30N4O2
Canonical SMILES: CCCCCOC1CCC(CC1)NC(=O)C2=C3N=C(C=C(N3N=C2)C)C
InChI: 1S/C20H30N4O2/c1-4-5-6-11-26-17-9-7-16(8-10-17)23-20(25)18-13-21-24-15(3)12-14(2)22-19(18)24/h12-13,16-17H,4-11H2,1-3H3,(H,23,25)
InChIKey: HZILSILAELSWKN-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 121327414
TTD ID: D05PFS

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)